Docket No. FMCSA-2012-0081], 65285-65286 [2015-27210]
Download as PDF
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 206 / Monday, October 26, 2015 / Notices
12, 2015. This collection is necessary in
order to determine applicants’
qualifications for certification as
Aviation Medical Examiners (AMEs).
DATES: Written comments should be
submitted by November 25, 2015.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the attention of the Desk Officer,
Department of Transportation/FAA, and
sent via electronic mail to oira_
submission@omb.eop.gov, or faxed to
(202) 395–6974, or mailed to the Office
of Information and Regulatory Affairs,
Office of Management and Budget,
Docket Library, Room 10102, 725 17th
Street NW., Washington, DC 20503.
Public Comments Invited: You are
asked to comment on any aspect of this
information collection, including (a)
Whether the proposed collection of
information is necessary for FAA’s
performance; (b) the accuracy of the
estimated burden; (c) ways for FAA to
enhance the quality, utility and clarity
of the information collection; and (d)
ways that the burden could be
minimized without reducing the quality
of the collected information. The agency
will summarize and/or include your
comments in the request for OMB’s
clearance of this information collection.
FOR FURTHER INFORMATION CONTACT:
Ronda Thompson at (202) 267–1416, or
by email at: Ronda.Thompson@faa.gov.
SUPPLEMENTARY INFORMATION:
OMB Control Number: 2120–0604.
Title: Aviation Medical Examiner
Program.
Form Numbers: FAA Form 8520–2.
Type of Review: Renewal of an
information collection.
Background: The Federal Register
Notice with a 60-day comment period
soliciting comments on the following
collection of information was published
on August 12, 2015 (80 FR 48391). 14
CFR part 183 describes the requirements
for delegating to private physicians the
authority to conduct physical
examinations on persons wishing to
apply for their airmen medial certificate.
This collection of information is for the
purpose of obtaining essential
information concerning the applicants’
professional and personal qualifications.
The FAA uses the information to screen
and select the designees who serve as
aviation medical examiners.
Respondents: Approximately 450
applicants annually.
Frequency: Information is collected
on occasion.
VerDate Sep<11>2014
18:53 Oct 23, 2015
Jkt 238001
Estimated Average Burden per
Response: 30 minutes.
Estimated Total Annual Burden: 225
hours.
Issued in Washington, DC, on October 14,
2015.
Ronda Thompson,
FAA Information Collection Clearance
Officer, IT Enterprises Business Services
Division, ASP–110.
[FR Doc. 2015–27171 Filed 10–23–15; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
Docket No. FMCSA–2012–0081]
Qualification of Drivers; Exemption
Applications; Implantable Cardioverter
Defibrillators
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of denials of exemption
applications.
AGENCY:
FMCSA announces its
decision to deny applications from 14 of
15 individuals seeking exemptions from
the Federal cardiovascular standard
applicable to interstate truck and bus
drivers and the reasons for the denials.
The Agency reviewed the medical
information of each of the individuals
who applied for an implantable
cardioverter defibrillator (ICD)
exemption. Because the medical
information received from the
cardiologist concerning one individual
indicates the ICD has been disabled due
to improvement of his heart function,
the exemption is no longer needed to
operate commercial motor vehicles
(CMVs) in interstate commerce. Based
on a review of the applications and
following an opportunity for public
comment, FMCSA has concluded that
the remaining 14 individuals in the
notice did not demonstrate they could
achieve a level of safety that is
equivalent to, or greater than, the level
of safety that would be obtained by
complying with the regulation.
DATES: Denial letters were sent to each
of the individuals listed in this notice
on July 24, 2015.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief Medical
Programs Division, 202–366–4001, U.S.
Department of Transportation, FMCSA,
1200 New Jersey Avenue SE., Room
W64–224, Washington, DC 20590–0001.
Office hours are from 8:30 a.m. to 5 p.m.
Monday through Friday, except Federal
holidays.
SUMMARY:
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
65285
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the Federal Motor Carrier Safety
Regulations for a 2-year period if it finds
‘‘such exemption would likely achieve a
level of safety that is equivalent to or
greater than the level that would be
achieved absent such exemption.’’
FMCSA can renew exemptions at the
end of each 2-year period.
On April 21, 2015, FMCSA published
for public notice and comment, FMCSA
2012–0081 listing 15 individuals
seeking exemptions for ICDs.
Accordingly, the Agency has evaluated
each applicant’s request to determine
whether granting an exemption will
achieve the required level of safety
mandated by statute.
Evaluation Criteria—Cardiovascular
Medical Standard and Advisory
Criteria
The individuals included in this
notice have requested an exemption
from the provisions of 49 CFR
391.41(b)(4), which applies to drivers
who operate CMVs in interstate
commerce, as defined in 49 CFR 390.5.
Section 391.41(b)(4) states that:
‘‘. . . a person is physically qualified to drive
a commercial motor vehicle if that person has
no current clinical diagnosis of myocardial
infarction, angina pectoris, coronary
insufficiency, thrombosis, or any other
cardiovascular disease of a variety known to
be accompanied by syncope (temporary loss
of consciousness due to a sudden decline in
blood flow to the brain), dyspnea (shortness
of breath), collapse, or congestive cardiac
failure.’’
The FMCSA provides medical
advisory criteria as recommendations
for use by medical examiners in
determining whether drivers with
certain medical conditions, procedures,
and/or treatments should be certified to
operate CMVs in interstate commerce in
accordance with the various physical
qualification standards in 49 CFR part
391, subpart E. The advisory criteria are
currently set out as part of the medical
examination report published with 49
CFR 391.43. The advisory criteria for
section 391.41(b)(4) provide that:
The term ‘‘has no current clinical diagnosis
of’’ is specifically designed to encompass: ‘‘a
clinical diagnosis of’’ (1) a current
cardiovascular condition, or (2) a
cardiovascular condition which has not fully
stabilized regardless of the time limit. The
term ‘‘known to be accompanied by’’ is
designed to include a clinical diagnosis of a
cardiovascular disease (1) which is
accompanied by symptoms of syncope,
dyspnea, collapse or congestive cardiac
failure; and/or (2) which is likely to cause
E:\FR\FM\26OCN1.SGM
26OCN1
65286
Federal Register / Vol. 80, No. 206 / Monday, October 26, 2015 / Notices
syncope, dyspnea, collapse, or congestive
cardiac failure.
It is the intent of the FMCSRs to render
unqualified, a driver who has a current
cardiovascular disease which is accompanied
by and/or likely to cause symptoms of
syncope, dyspnea, collapse, or congestive
cardiac failure. However, the subjective
decision of whether the nature and severity
of an individual’s condition will likely cause
symptoms of cardiovascular insufficiency is
on an individual basis and qualification rests
with the medical examiner and the motor
carrier.
In the case of persons with ICDs, the
underlying condition for which the ICD
was implanted places the individual at
high risk for syncope (a transient loss of
consciousness) or other unpredictable
events known to result in gradual or
sudden incapacitation. ICDs may
discharge, which could result in loss of
ability to safely control a CMV. See the
Evidence Report on Cardiovascular
Disease and Commercial Motor vehicle
Driver Safety, April 2007.1 A focused
research report on Implantable
Cardioverter Defibrillators and the
Impact of a Shock on a Patient When
Deployed completed for the FMCSA
December 2014 indicates that the
available scientific data on persons with
ICDs and CMV driving does not support
that persons with ICDs who operate
CMVs are able to meet an equal or
greater level of safety and upholds the
findings of the April 2007 report.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Discussion of Public Comments
On April 21, 2015, FMCSA published
in a Federal Register Notice, the names
of 15 individuals requesting ICD
exemption and requested public
comment. The public comment period
closed on May 21, 2015. A total of 29
commenters responded to the notice.
The majority of commenters were in
favor of the applicants continuing to
drive CMV’s with ICD’s. Commenters
believed that the individuals seeking
exemptions were responsible drivers
who had safe driving histories and were
compliant with their medical treatment
programs. One anonymous commenter
encouraged the FMCSA not to grant
these individuals exemptions due to
concerns of the risks of the underlying
medical conditions in combination with
operating a commercial motor vehicle.
FMCSA’s Response
FMCSA acknowledges the
commenters’ reports of medical
compliance and safe driving histories of
the applicants. However, based on the
available medical literature and data,
FMCSA believes that drivers with an
1 Now available at https://ntl.bts.gov/lib/30000/
30100/30123/Final_CVD_Evidence_Report_v2.pdf.
VerDate Sep<11>2014
18:53 Oct 23, 2015
Jkt 238001
ICD are at risk for incapacitation if the
device discharges in response to
cardiovascular symptoms. This risk is
combined with the risks associated with
the underlying cardiovascular condition
for which the ICD has been implanted
as a primary or secondary preventive
measure.
Mr. Leslie Mitchell no longer has a
functioning ICD and may operate CMVs
in interstate commerce based on the
decision of the medical examiner. Mr.
Mitchell has a pacemaker/ICD but the
ICD portion was disabled because his
cardiologist determined he no longer
needs tachycardia therapy. Therefore, if
a medical examiner determines that he
meets the cardiovascular standard and
all other physical qualification
standards for operating a commercial
motor vehicle in interstate commerce,
he may be issued a medical certificate.
Conclusion
FMCSA evaluated the remaining 14 of
15 individual exemption requests on
their merits, available data from
Evidence Reports and Medical Expert
Panel opinions on ICDs and commercial
motor vehicle driving, and the public
comments received. The Agency has
determined that the available medical
literature and data does not support a
conclusion that granting these
exemptions would achieve a level of
safety equivalent to or greater than, the
level of safety maintained without the
exemptions. Each applicant has, prior to
this notice, received a letter of final
disposition on his/her exemption
request. Those decision letters fully
outlined the basis for the denial and
constitute final Agency action. The list
published today summarizes the
Agency’s recent denials as required
under 49 U.S.C. 31315(b)(4).
The following 14 applicants are
denied exemptions from the
cardiovascular standard concerning
ICDs.
Craig Bohms
James Dean
Terry Goodhile
David Allan Jensen
Michael Politz
Charles Rhodes
Mark Steiner
Daniel Donahue
Bernard Fritzson
Ronald Heinlein
Douglas Lopez
Mark Register
Stephen Watts
John Allen Weltz
Issued on: October 15, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–27210 Filed 10–23–15; 8:45 am]
BILLING CODE 4910–EX–P
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
DEPARTMENT OF TRANSPORTATION
Pipeline and Hazardous Materials
Safety Administration
[Docket ID PHMSA–2014–0092]
Pipeline Safety: National Pipeline
Mapping System; Extension of
Comment Period and Notice of
Operator Workshop
Pipeline and Hazardous
Materials Safety Administration
(PHMSA), DOT.
ACTION: Notice and request for
comments; extension of comment
period and announcement of a National
Pipeline Mapping System Operator
Technical Workshop.
AGENCY:
PHMSA is sponsoring a oneday National Pipeline Mapping System
(NPMS) operator technical workshop on
November 18, 2015, at a Washington,
DC area hotel. This notice also
announces that the comment period for
the 60-day information collection
published on August 27, 2015, (80 FR
52084) is extended until November 25,
2015, in order to conduct this workshop
that will provide PHMSA with
important information as it prepares to
improve the NPMS submission process
to accept additional data.
DATES: The NPMS operator technical
workshop will be held on November 18,
2015, at a Washington, DC-area hotel,
from 8:00 a.m. to 5:00 p.m. The
comment period for the 60-day
information collection published on
August 27, 2015 (80 FR 52084) is
extended from October 26, 2015 to
November 25, 2015.
ADDRESSES: The workshop location, and
hotel information will be announced in
PRIMIS at https://primis.phmsa.dot.gov/
meetings/MtgHome.mtg?mtg=107 once
the conference room space has been
procured.
FOR FURTHER INFORMATION CONTACT:
Amy Nelson at 202–493–0591 or by
email at amy.nelson@dot.gov.
SUPPLEMENTARY INFORMATION: The
purpose of the workshop is to discuss
and understand existing and future
NPMS submission technical issues such
as (1) the format in which operators are
storing the data that is submitted to the
NPMS, (2) how pipe segmentation for
the submissions is determined, (3) how
data is submitted in a linear referencing
format, and (4) options Geographic
Information Systems technicians have
when an attribute includes the word
‘‘predominant’’ (i.e., submitting actual
data or rolling up data to create a
‘‘predominant’’ value). This workshop
will not discuss any proposed new data
SUMMARY:
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 80, Number 206 (Monday, October 26, 2015)]
[Notices]
[Pages 65285-65286]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-27210]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
Docket No. FMCSA-2012-0081]
Qualification of Drivers; Exemption Applications; Implantable
Cardioverter Defibrillators
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of denials of exemption applications.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to deny applications from 14 of
15 individuals seeking exemptions from the Federal cardiovascular
standard applicable to interstate truck and bus drivers and the reasons
for the denials. The Agency reviewed the medical information of each of
the individuals who applied for an implantable cardioverter
defibrillator (ICD) exemption. Because the medical information received
from the cardiologist concerning one individual indicates the ICD has
been disabled due to improvement of his heart function, the exemption
is no longer needed to operate commercial motor vehicles (CMVs) in
interstate commerce. Based on a review of the applications and
following an opportunity for public comment, FMCSA has concluded that
the remaining 14 individuals in the notice did not demonstrate they
could achieve a level of safety that is equivalent to, or greater than,
the level of safety that would be obtained by complying with the
regulation.
DATES: Denial letters were sent to each of the individuals listed in
this notice on July 24, 2015.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief Medical
Programs Division, 202-366-4001, U.S. Department of Transportation,
FMCSA, 1200 New Jersey Avenue SE., Room W64-224, Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday,
except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' FMCSA can renew exemptions at the end of each
2-year period.
On April 21, 2015, FMCSA published for public notice and comment,
FMCSA 2012-0081 listing 15 individuals seeking exemptions for ICDs.
Accordingly, the Agency has evaluated each applicant's request to
determine whether granting an exemption will achieve the required level
of safety mandated by statute.
Evaluation Criteria--Cardiovascular Medical Standard and Advisory
Criteria
The individuals included in this notice have requested an exemption
from the provisions of 49 CFR 391.41(b)(4), which applies to drivers
who operate CMVs in interstate commerce, as defined in 49 CFR 390.5.
Section 391.41(b)(4) states that:
``. . . a person is physically qualified to drive a commercial motor
vehicle if that person has no current clinical diagnosis of
myocardial infarction, angina pectoris, coronary insufficiency,
thrombosis, or any other cardiovascular disease of a variety known
to be accompanied by syncope (temporary loss of consciousness due to
a sudden decline in blood flow to the brain), dyspnea (shortness of
breath), collapse, or congestive cardiac failure.''
The FMCSA provides medical advisory criteria as recommendations for
use by medical examiners in determining whether drivers with certain
medical conditions, procedures, and/or treatments should be certified
to operate CMVs in interstate commerce in accordance with the various
physical qualification standards in 49 CFR part 391, subpart E. The
advisory criteria are currently set out as part of the medical
examination report published with 49 CFR 391.43. The advisory criteria
for section 391.41(b)(4) provide that:
The term ``has no current clinical diagnosis of'' is
specifically designed to encompass: ``a clinical diagnosis of'' (1)
a current cardiovascular condition, or (2) a cardiovascular
condition which has not fully stabilized regardless of the time
limit. The term ``known to be accompanied by'' is designed to
include a clinical diagnosis of a cardiovascular disease (1) which
is accompanied by symptoms of syncope, dyspnea, collapse or
congestive cardiac failure; and/or (2) which is likely to cause
[[Page 65286]]
syncope, dyspnea, collapse, or congestive cardiac failure.
It is the intent of the FMCSRs to render unqualified, a driver
who has a current cardiovascular disease which is accompanied by
and/or likely to cause symptoms of syncope, dyspnea, collapse, or
congestive cardiac failure. However, the subjective decision of
whether the nature and severity of an individual's condition will
likely cause symptoms of cardiovascular insufficiency is on an
individual basis and qualification rests with the medical examiner
and the motor carrier.
In the case of persons with ICDs, the underlying condition for
which the ICD was implanted places the individual at high risk for
syncope (a transient loss of consciousness) or other unpredictable
events known to result in gradual or sudden incapacitation. ICDs may
discharge, which could result in loss of ability to safely control a
CMV. See the Evidence Report on Cardiovascular Disease and Commercial
Motor vehicle Driver Safety, April 2007.\1\ A focused research report
on Implantable Cardioverter Defibrillators and the Impact of a Shock on
a Patient When Deployed completed for the FMCSA December 2014 indicates
that the available scientific data on persons with ICDs and CMV driving
does not support that persons with ICDs who operate CMVs are able to
meet an equal or greater level of safety and upholds the findings of
the April 2007 report.
---------------------------------------------------------------------------
\1\ Now available at https://ntl.bts.gov/lib/30000/30100/30123/Final_CVD_Evidence_Report_v2.pdf.
---------------------------------------------------------------------------
Discussion of Public Comments
On April 21, 2015, FMCSA published in a Federal Register Notice,
the names of 15 individuals requesting ICD exemption and requested
public comment. The public comment period closed on May 21, 2015. A
total of 29 commenters responded to the notice. The majority of
commenters were in favor of the applicants continuing to drive CMV's
with ICD's. Commenters believed that the individuals seeking exemptions
were responsible drivers who had safe driving histories and were
compliant with their medical treatment programs. One anonymous
commenter encouraged the FMCSA not to grant these individuals
exemptions due to concerns of the risks of the underlying medical
conditions in combination with operating a commercial motor vehicle.
FMCSA's Response
FMCSA acknowledges the commenters' reports of medical compliance
and safe driving histories of the applicants. However, based on the
available medical literature and data, FMCSA believes that drivers with
an ICD are at risk for incapacitation if the device discharges in
response to cardiovascular symptoms. This risk is combined with the
risks associated with the underlying cardiovascular condition for which
the ICD has been implanted as a primary or secondary preventive
measure.
Mr. Leslie Mitchell no longer has a functioning ICD and may operate
CMVs in interstate commerce based on the decision of the medical
examiner. Mr. Mitchell has a pacemaker/ICD but the ICD portion was
disabled because his cardiologist determined he no longer needs
tachycardia therapy. Therefore, if a medical examiner determines that
he meets the cardiovascular standard and all other physical
qualification standards for operating a commercial motor vehicle in
interstate commerce, he may be issued a medical certificate.
Conclusion
FMCSA evaluated the remaining 14 of 15 individual exemption
requests on their merits, available data from Evidence Reports and
Medical Expert Panel opinions on ICDs and commercial motor vehicle
driving, and the public comments received. The Agency has determined
that the available medical literature and data does not support a
conclusion that granting these exemptions would achieve a level of
safety equivalent to or greater than, the level of safety maintained
without the exemptions. Each applicant has, prior to this notice,
received a letter of final disposition on his/her exemption request.
Those decision letters fully outlined the basis for the denial and
constitute final Agency action. The list published today summarizes the
Agency's recent denials as required under 49 U.S.C. 31315(b)(4).
The following 14 applicants are denied exemptions from the
cardiovascular standard concerning ICDs.
Craig Bohms
James Dean
Terry Goodhile
David Allan Jensen
Michael Politz
Charles Rhodes
Mark Steiner
Daniel Donahue
Bernard Fritzson
Ronald Heinlein
Douglas Lopez
Mark Register
Stephen Watts
John Allen Weltz
Issued on: October 15, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015-27210 Filed 10-23-15; 8:45 am]
BILLING CODE 4910-EX-P